Genetic News and Research

RSS

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.

5 Oct 2013

Trial to determine effectiveness of sun protection program for children of melanoma survivors

Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research.

5 Oct 2013

Study identifies new potential genetic culprits in origins of congenital heart defects

Mitochondria are the power plants of cells, manufacturing chemical fuel so a cell can perform its many tasks. These cellular power plants also are well known for their role in ridding the body of old or damaged cells.

5 Oct 2013

Merck Canada Awards $15.5M To Four Universities

...

4 Oct 2013

Designer Baby Patent Awarded To 23Andme

...

4 Oct 2013

Eppendorf Sponsoring Shared Lab Space At Cambridge, MA

Eppendorf North America is now a sponsor of LabCentral, a shared laboratory space designed to be a catalyst for entrepreneurs and life science startups. The 27,000 square-foot facility is slated for opening November 1, 2013, and will be located at Kendall Square, Cambridge, MA, in the Cambridge Biotech Innovation Hub.

From Eppendorf 4 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

Autism Speaks launches the Preclinical Autism Consortium for Therapeutics

Autism Speaks, the world's leading autism science and advocacy organization, today announced the launch of the Preclinical Autism Consortium for Therapeutics (PACT).

4 Oct 2013

Cholesterol-lowering drugs could be alternative treatment for people who take statins

A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique’s feasibility and safety.

4 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

Penn Medicine receives $12M NIHM grant for genetics study that points causes of mental illness

A major international consortium co-led by Penn Medicine has received a $12 million National Institute of Mental Health (NIHM) grant for a large-scale genetics study investigating why patients with chromosome 22q11.2 deletion syndrome have an increased risk of schizophrenia and other psychiatric disorders.

4 Oct 2013

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.

4 Oct 2013

CHOP’s 22q and You Center plays major role in brain and behavior consortium

Genetics experts from The Children's Hospital of Philadelphia (CHOP) are among the top leaders of a major international collaboration researching why patients with chromosome 22q11.2 deletion syndrome have an elevated risk of schizophrenia and other psychiatric illnesses.

4 Oct 2013

Genetically modified bacterial treatment approach reduces or eliminates sleeping sickness

A tag team of two bacteria, one of them genetically modified, has a good chance to reduce or even eliminate the deadly disease African trypanosomiasis, or sleeping sickness, researchers at Oregon State University conclude in a recent mathematical modeling study.

4 Oct 2013

Whitehead Institute researchers redefine gene mutation that cause Rett syndrome

Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found in the neurons of Rett syndrome patients and could lead to novel therapies for the disease.

4 Oct 2013

NYU researchers receive $6.25M grant for pioneering research into acute lymphoblastic leukemia

Researchers at The Cancer Institute at NYU Langone Medical Center is leading a $6.25 million, five-year research initiative, funded by the Leukemia & Lymphoma Society, to develop new therapies and advance the cure rate for children and young adults with acute lymphoblastic cancer (ALL), the most common form of childhood cancer.

4 Oct 2013

Genetic News and Research

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Trial to determine effectiveness of sun protection program for children of melanoma survivors

Study identifies new potential genetic culprits in origins of congenital heart defects

Merck Canada Awards $15.5M To Four Universities

Designer Baby Patent Awarded To 23Andme

Eppendorf Sponsoring Shared Lab Space At Cambridge, MA

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

Autism Speaks launches the Preclinical Autism Consortium for Therapeutics

Cholesterol-lowering drugs could be alternative treatment for people who take statins

Cynvenio launches ClearID Breast Cancer monitoring program

Penn Medicine receives $12M NIHM grant for genetics study that points causes of mental illness

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

CHOP’s 22q and You Center plays major role in brain and behavior consortium

Genetically modified bacterial treatment approach reduces or eliminates sleeping sickness

Whitehead Institute researchers redefine gene mutation that cause Rett syndrome

NYU researchers receive $6.25M grant for pioneering research into acute lymphoblastic leukemia

MRC Tech, Renishaw Collaborate To Develop Infectious Disease Diagnostics

J&J's Janssen Companies Launch A Trio Of Collaborations

X-Chem, Astrazeneca Expand Drug Discovery Collab

Aaipharma Merges With Cambridge Major Laboratories

Sequencing & Genomics: Elevating Science and Healthcare eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News